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Purpose: We reviewed an 18-year experience with combined abdominal aortic and renal 
artery reconstruction (AOR) with a particular focus on patients' clinical risk profile and 
surgical results in contemporary practice as compared with earlier experience. 
Methods: One hundred seventy patients underwent AOR during the interval January 1, 
1976 to June 30, 1994. To examine parameters epresentative of current practice, the 
cohort was divided into group I patients (n = 110) treated before 1990 and group II 
(n = 60) treated between 1990 and 1994. Median follow-up duration for the entire cohort 
was 8.4 + 0.6 years. Renal artery reconstruction patency and patient survival rates were 
calculated by life-table methods. Logistic and Cox regression analysis were used to 
determine predictors of perioperative and long-term morbidity/mortality rates. 
Results: Although demographic features changed little over the review period, the 
detection (56% vs 73%, p = 0.03) and treatment with percutaneous transluminal 
coronary angioplasty/coronary tery bypass grafting (11% vs 40%, p = 0.0001) of 
associated coronary artery disease were more frequent in group II versus group I patients. 
Alternatively, renal insufficiency was more frequent in group I patients. The operative 
mortality rate for the entire cohort was 6.5% (group I = 9% vs group II = 2%,p = 0.06). 
Changing trends of surgical techniques over the review period included (group I vs II, 
respectively) increased use of bilateral simultaneous renal artery repair (12% vs 25%, 
p < 0.005) and transaortic endarterectomy as the renal artery reconstruction technique 
(3% vs 25%,p < 0.0001). Favorable response in blood pressure control was noted in 68% 
of group II patients. The cumulative 5-year survival rate for all patients was 75% with an 
initial serum creatinine of 2.0 mg/dl or greater being the only negative predictor of late 
survival after regression analysis. 
Conclusion: The current operative mortality rate for AOR is in the range anticipated for 
aortic surgery alone, and this appears to be related to improved etection and treatment 
of associated coronary artery disease and intervention before major deterioration i  renal 
fimction. These findings coupled with currently available natural history data relative to 
renovascular disease justify an aggressive approach with AOR when significant renal artery 
stenosis is detected uring evaluation of aortic disease. (J VASC SUWG 1995;21:916-25.) 
Patients treated with simultaneous aortic and 
renal artery reconstruction are a heterogenous group 
with respect o both clinical presentation and func- 
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tional consequences of the renal artery lesion. The 
focus of clinical presentation may be referable to 
either the aortic disease or the renovascular disease, 
or, not uncommonly, both lesions may present 
independent indications for intervention. In addi- 
tion, the combined operation may be indicated 
irrespective of renal artery occlusive disease, such as 
in the circumstance of accessory renal arteries arising 
from the diseased aortic segment. 
Renovascnlar disease is discovered in the course 
of angiographic nvestigation of aortic disease in up 
to one third of  patients.~3 Whether the renovascular 
disease requires concomitant surgical correction re- 
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mains a controversial issue, particularly in the cir- 
cumstance where the renal artery lesion is clinically 
silent. Those who advocate a conservative posture to 
such patients emphasize the increased surgical risk of 
a combined reconstruction compared with either 
procedure performed independently. Irrespective of 
concerns about operative safety, judgements about 
when to add a renal artery repair to aortic reconstruc- 
tion have been hampered by a lack of natural history 
data concerning particularly the renal artery stenosis. 
Recently available natural history studies of renal ar- 
tery occlusive disease, particularly that discovered 
during the course of evaluation of aortic disease, sug- 
gest hat progression of high-grade r nal artery steno- 
sis is both common and frequently accompanied by 
clinical deterioration, which is to a degree irreversible 
once progression to total renal artery occlusion has 
occurred. 4's Therefore these authors have recom- 
mended repair of high-grade r nal artery stenosis be- 
cause of the anticipated morbid course of the disease 
if left untreated. In addition, other factors have con- 
tributed to an increasing application of the combined 
operation. These include improved surgical results 
with respect to operative safety. Contemporary e- 
ports detailing operative mortality rates of 5% or less 
for the combined operation are commonplace. 69 In 
addition, an increasing awareness ofthe role ofreno- 
vascular disease in the development of chronic renal 
insufficiency, ~°and the demonstrated durability of 
renal artery reconstruction, ~ have fostered increasing 
aggressiveness toward even "asymptomatic" renal ar- 
tery lesions. All of these factors are flected in recent 
reports detailing treatment of atherosclerotic reno- 
vascular disease, which indicate that simultaneous 
aortic and renal artery operation isapplied frequently 
(range 20% to 60%). ll'14 
The above noted clinical trends and a sobering 
8.5% mortality rate for the combined operation in a 
prior study of renovascular reconstruction from our 
group H prompted a review of our experience with 
simultaneous aortic and renal artery reconstruction 
over a consecutive 18-year period. We emphasize the 
changing clinical profile of such patients and the 
improved results in current practice with the com- 
bined operation. 
PATIENTS AND METHODS 
During the interval January 1, 1976 to May 30, 
1994, 170 consecutive patients underwent combined 
abdominal ortic grafting and reconstructions of one 
or more renal arteries that harbored atherosclerotic 
stenotic lesions. Reimplantation of nonstenotic ac- 
cessory or main renal arteries or routine, obligatory 
reconstruction carried out, for example, during the 
course of thoracoabdominal aneurysm repair were 
excluded. Clinical, demographic, and follow-up data 
were obtained from hospital and physician/surgeon 
records. To assess the clinical variables and results of 
contemporary surgical therapy more accurately, the 
study group was divided into two cohorts: group I
patients treated between 1976 and 1989 and group 
II treated from 1990 to 1994. Patients treated uring 
the interval 1990 to 1994 had return visits for a 
current assessment of the status of their renal artery 
reconstruction (with renal scintigraphy, angiogra- 
phy, or on clinical grounds when repair was to a 
single kidney), blood pressure control and serum 
creatinine. A history of hypertension a d medications 
prescribed for same was recorded. Hypertension was 
considered poorly controlled if diastolic blood pres- 
sure was 95 mm Hg or greater on multiple determi- 
nations after admission to the hospital on medical 
therapy. A favorable response t:o renal artery recon- 
struction with respect o hypertension was consid- 
ered if hypertension was cured or improved by 
criteria established in the original Cooperative Study 
on Renovascular Hypertension. is (Cured patients 
had normal blood pressure (BP)-  diastolic BP less 
than 90-without medications; patients considered 
improved had normal blood pressure while trader- 
going therapy or had diastolic pressures at least 15% 
below preoperative l vels.) The mode of clinical 
presentation, that is either primarily for renovascular 
disease, aortoiliac occlusive disease, abdominal ortic 
aneurysm, or simultaneous treatment of aortic dis- 
ease and renovascular disease was recorded. Patients 
were considered to have a single functioning kidney 
if any of the following criteria were met: (1) 
surgically or congenitally absent kidney; (2) a kid- 
ney with no visible nephrogram after contrast ar- 
teriography; or (3) negligible (<10% of total) 
fimction in one kidney as seen with technetium 99 
renal scintigraphy. All patients were evaluated with 
contrast arteriography; renal artery anatomy was 
classified as "stenosis" if 50% or greater diameter 
reduction was noted. Operative mortality considered 
death within 30 days of surgery. Total operative time 
and total operative blood turnover ("excess" blood 
loss _ 1 L transfusions) were assessed from the 
anesthesia record. Major cardiac or pulmonary com- 
plications included the requirement for mechanical 
ventilation for longer than 48 hours after operation, 
pneumonia requiring intravenous antibiotics and 
verified by chest radiography, any myocardial infarc- 
tion as documented by sequential cardiac enzymes 
irrespective of clinical sequelae, any cardiac arrhyth- 
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Table I. Demographic features of 170 patients treated with combined aortic and renal 
artery reconstruction 
Group 1 (n = Ho) Group 2 (n = 60) 
Variable No. % No. % p Value 
Male sex 61 55 36 60 ns 
Diabetes 16 14 9 15 ns 
Smoking 39 35 31 52 0.005 
Age > 70 yrs. 41 37 29 48 ns 
Mean age (yrs.) 67 68 ns 
mia, heart failure or unstable angina requiring 
transfer to an intensive care unit, or any other cardiac 
complication considered to prolong hospitalization. 
Other cardiac and pulmonary events were considered 
minor complications. Kidney-related complications 
were considered major if there was a need for 
postoperative dialysis where the patient had not been 
undergoing dialysis before operation or a more than 
doubling of the baseline serum creatinine. Lesser 
degrees of elevation of serum creatinine in the 
perioperative p riod were considered minor kidney- 
related complications. 
Statistical analysis 
All statistical computations were performed on a 
DEC VAX-11780 computer (Digital Equipment 
Corp., Maynard, Mass.) with the use of the following 
(BMDP Software Inc., Los Angeles, Calif.) statistical 
programs: BMDP4F (frequency tables), BMDP2L 
(Cox proportional hazards regression). Frequency 
tables were analyzed for statistical significance by use 
of chi-squared or Fisher exact ests. Life-tables were 
constructed for determination f long-term cumula- 
tive renal artery graft patency and survival rates. 
Stepwise logistic regression was used to determine 
independent risk factors for perioperative endpoints 
(death, major complications) from univariate predic- 
tors, and stepwise Cox regression was used to identify 
independent risk factors for late death. Adjusted odds 
ratios and relative risk estimates ( _+ 95% confidence 
limits) were derived from logistic and Cox coeffi- 
cients, respectively, for all significant (p < 0.05) risk 
factors. 
RESULTS 
Patients dlnical profile 
Patient demographic features are detailed in 
Table I, and, with the exception of a higher percent- 
age of smokers in group II patients, no major changes 
in the demographic features were noted as function of 
treatment era. In contrast, here were striking differ- 
ences in clinical features referable to associated 
coronary artery disease and the sequelae of renovas- 
cular disease between groups I and II. As displayed in 
Table II, documented coronary artery disease (CAD) 
and interventional treatment thereof was common- 
place in recently treated patients. Alternatively, the 
morbid consequences ofrenovascular disease includ- 
ing renal insufficiency and the presence of a single 
functioning kidney were more prevalent among 
group I patients. Despite these differences in clinical 
profile over time, there was little difference over the 
18-year study period with respect o the mode of 
clinical presentation; 54% of patients initially were 
evaluated on referral for abdominal ortic aneurysms 
(AAA), 17% for symptomatic manifestations of 
aortoiliac occlusive disease, whereas nearly one third 
of patients (29%) were referred either primarily for 
renovascular disease or with knowledge that both 
aortic and renal rtery disease required therapy. One 
third of AAA were juxtarenal (aneurysm neck ___ 1 
cm) or suprarenal in extent, requiring suprarenal or 
supraceliac lamping. Although no attempt was 
made to document a renovascular cause for hyper- 
tension, some 95% of all patients had hypertension, 
and less than 5 % of patients underwent correction of 
renal artery stenosis (RAS) in the absence of hyper- 
tension or some degree of renal insufficiency. Poorly 
controlled hypertension was noted in 42% of all 
patients (group I = 47%, group II = 33%, 
p < 0.15), and group II patients were given an 
average of 2.5 antihypertensive medications. Ex- 
treme degrees of renal insufficiency (creatinine _> 3.0 
mg/dl) were noted in some 12% of all patients, but 
only one patient was undergoing dialysis before 
surgery. Throughout the study period some 40% of 
patients had bilateral RAS of 50% or greater as 
assessed by contrast arteriography. However, repair 
was restricted tohigh-grade l sions, that is those with 
75% or greater diameter stenosis. 
Surgical treatment and hospital course 
With respect to the details of surgical treatment, 
a unilateral aortorenal prosthetic graft was the single 
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Table II. Clinical profile of patients by treatment era 
Group I (n = 110) Croup ~ (n = 60) 
Variable No. % No. % p Value 
History of CAD 62 56 44 73 .029 
History of PTCA/CABG 12 11 24 40 .0001 
Creatinine > 1.5 mg/dl 59 54 20 33 .010 
Single functioning kidney 38 34 7 12 .001 
AAA and single functioning 20 18 4 7 .03 
kidney 
PTCA, Percutaneous transluminal coronary angioplasty. 
most frequently used method of renal artery recon- 
struction (80% of all patients). Specific tenets of 
surgical treatment that could be identified as chang- 
ing over the course of the review included (group I
vs group II, respectively) bilateral renal artery recon- 
struction (12% vs 25%, p < 0.005) and use of 
transaortic endarterectomy for renal artery recon- 
struction (3% vs 25%, p < 0.001). In addition, 
group II patients underwent aortic reconstruction via 
a retroperitoneal approach in 30% of cases, whereas 
this technique was rarely used in our earlier experi- 
ence. Surgical complications and death over the study 
interval are detailed in Table III. The overall opera- 
tive mortality rate during the 18-year study period 
was 6.5%, the bulk of which (all but one patient) 
occurred in group I patients. Fifty percent of 
perioperative deaths and one third of all late deaths 
were related to heart disease. Of a variety of clinical 
and operative variables analyzed by logistic regres- 
sion, only age greater than 70 years at time of surgery 
was correlated with surgical death (odds ratio (OR): 
4.5; 95% confidence interval (CI): 1.2 to 18.9; 
p < 0.02) in group I patients. However, this variable 
of advanced age was diluted and failed to achieve 
significance after consideration of all patients. This 
suggested that current surgical results in elderly 
patients had improved. Most deaths (5 of 10) in 
group I patients were related to cardiac complica- 
tions, with other causes being kidney failure (n = 1) 
perforated ulcer (n = 1), and hemorrhage (n = 3). 
The single operative death in group II patients was 
related to intraoperative hemorrhage. If the entire 
cohort is considered, the only factor associated with 
operative death was an abnormal serum creatinine 
(OR: 3.8; 95% CI: 1.9 to 8; p < 0.02). Major 
cardiac complications occurred in two patients in 
group II, whereas pulmonary complications (7of 60, 
12%) continue to be the principal source of morbid- 
ity. Major renal complications occurred in 6% of all 
patients, and in reviewing the entire cohort, a normal 
serum creatinine before operation was associated 
with freedom from perioperative complications 
(p < 0.03). Similarly, extreme degrees of renal 
dysfunction (creatinine > 3.0) was a univariate pre- 
dictor of perioperative complications, with 24% of all 
such patients having one or more major complication 
(p < 0.02). Variables predictive of all major compli- 
cations (n = 11 patients) in group II patients in- 
cluded only the surgical factors of prolonged (,> 5 
hours) operative time (OR: 5.1; 95% CI: 1.4 to 30; 
p < 0.02) and excess bloodloss (OR: 15.6; 95% CI: 
2 to 125; p < 0.05). Variables examined but not 
predictive of major operative complications ncluded 
the demographics and clinical variables listed in 
Tables I and II and the following surgical factors: 
operation for AAA versus A~[OD, retroperitoneal 
versus transperitoneal operative route, single versus 
bilateral renal artery reconstruction and extent of 
aortic graft (tube versus bifurcated graft). In group II 
patients the functional result (hypertension and 
serum creatinine r sponse) of renovascular repair was 
assessed both at discharge from the hospital and at 
the follow-up visit. Whereas "cure" of hypertension 
was uncommon (8% of patients), 78% of patients 
experienced arly improvement in hypertension con- 
trol. Although there was some deterioration in blood 
pressure response aft r operation (68% of 57 patients 
cured or improved at mean follow-up of 1.8 years), 
improvement in blood pressure control after opera- 
tion was strongly predictive of a good long-term 
response with 90% of initially responding patients 
having sustained improvement in blood pressure 
control. 
Late outcome 
Interval failure of renal artery reconstruction was 
uncommon. Cumulative patency of the renal artery 
reconstructions by life-table analysis at the 5-year 
interval was 91%. A similar figure (90%) was noted 
for the patency rate of group II patients' renovascular 
reconstruction at the 2-year interval when half of 
these 60 patients were still in the life-table analysis. 
Seventy-five percent of eligible group II patients had 
late (operation longer than 6 months before follow- 
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Table III. Perioperative r sults 
Group X (n = HO) Group H (n = 60) 
Factor No. % No. % p Value 
Operative mortality rate 10 9 1 1.7 0.06 
Early renal artery reconstruction 2 1.8 1 1.7 ns 
failure 
Major complications ~ 26 23.6 11 18.3 ns 
~Includes major cardiac, pulmonary, and renal complications as defined in text. 
up) confirmation of renal artery patency by renal 
scanning or repeat angiography. Survival for the 
entire cohort (after censoring the 11 postoperative 
deaths) by life-table analysis is displayed in Table IV, 
with follow-up beyond the 10-year interval truncated 
because of small numbers. The cumulative survival 
rate after operation was 75% at the 5-year interval. 
Factors associated with late death after univariate 
analysis are displayed in Table V. The sequelae of 
renovascular disease had a negative impact on late 
survival, whereas a favorable blood pressure response 
to operation improved outcome. Mechanical inter- 
vention for CAD had a favorable impact on survival, 
but this variable did not achieve statistical signifi- 
cance. After multivariate regression analysis only a 
baseline creatinine of 2 mg/dl or greater (relative risk: 
3.1; 95% CI: 1.5 to 6.2; p < 0.002) achieved 
significance as a predictor of late death. Interval death 
in group II patients occurred in seven (cardiac 
In = 2], stroke In = 2], carcinoma In = 2], mesen- 
teric infarct [n = 1]) cases. Despite small numbers, 
identified cholesterol emboli to the kidney was 
predictive of a poor late outcome (relative risk: 6.0; 
95% CI: 1.3 to 33; p < 0.03). Response to opera- 
tion with respect to renal function could be assessed 
for group II patients at a mean follow-up duration of 
1.8 years. Among those patients with a baseline 
creatinine of 1.5 mg/di or less, only three patients 
( < 10%) experienced deterioration i  renal function 
( _ 20% increase from baseline creatinine), none to a 
clinically significant degree. Among the 20 patients 
with initial creatinine of 1.5 or greater, some 25% 
had deterioration i  renal fi.mction, with the condi- 
tions of the remainder stabilized (25%) or improved 
(50%). In one patient dialysis was discontinued after 
operation, whereas another patient (with an initial 
creatinine of 4.0 and cholesterol emboli syndrome) 
required the institution of permanent dialysis 4 
months after operation. 
DISCUSSION 
Potential candidates for combincd aortic and 
renal artery reconstruction represent a wide spectrum 
with respect to the indications for intervention for 
each lesion. Multiple judgmental nd technical fac- 
tors, including the extent and clinical manifestations 
of the aortic disease, patient comorbid factors, and 
the functional significance (if any), and anatomy of 
the renovascular disease guarantee that no single 
approach will be uniformly applicable to these 
patients. This heterogeneity not withstanding, com- 
bined operations are being performed more fre- 
quently in current practice. In the 18-year consecu- 
tive experience detailed in this report, combined 
operation iscurrently performed in our unit at a rate 
nearly two times more frequently than before 1990. 
Branchureau et al.6 surveyed the practice of combined 
operation and noted in a collective review of 10 
clinical series published up to 1988 that a mean of 
5.7% (range 3% to 18%) of aortic reconstructions 
were complemented with a renal artery graft. 6In a 
prior review of major reports published since 1984 
and representing experience with nearly 1000 pa- 
tients, we noted the corresponding figure to be 
8.6%.  16 On our service over the past 5 years, the 
combined operation represents ome 8% of all 
abdominal aortic reconstructions and 50% of all 
surgical renal artery reconstructions; it is the single 
most frequently applied technique in patients who 
undergo surgery for atherosclerotic renal artery 
obstruction. In an era of increasing awareness of the 
importance of renovascular disease l°and the fact that 
such patients typically have diffuse atherosclerosis, 
considerations for combined operation seem likely to 
increase. 
Technical considerations 
A variety of surgical staging schemes, reconstruc- 
tive techniques, and adjunctive use of renal artery 
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Table IV. Long-term survival after combined aortic and renal artery reconstruction 
Cumulative proportion 
No. of patients Proportion surviving at beginning 
Interval yrs. entered Withdrawn Dead Proportion dead  surviving of interval 
0-1 159 48 8 0.0593 0.9407 1.0000 
1-2 103 13 4 0.0415 0.9585 0.9407 
2-3 86 13 6 0.0755 0.9245 0.9017 
3-4 67 19 3 0.0522 0.9478 0.8337 
4-5 45 11 2 0.0506 0.9494 0.7902 
5-6 32 6 1 0.0345 0.9655 0.7502 
6-7 25 4 0 0.0000 1.0000 0.7243 
7-8 21 2 5 0.2500 0.7500 0.7243 
8-9 14 1 3 0.2222 0.7778 0.5432 
9-10 10 1 2 0.2105 0.7895 0.4225 
Table V. Univariate predictors of late death after combined aortic and renal artery reconstruction s 
Late survivors (n = 123) Late deaths (n = 36) 
Variable No. % No. % p Value 
Male sex 66 54 25 69 0.102 
Age -> 70 years 49 40 11 31 0.297 
Diabetes 18 15 5 14 0.897 
History of CAD 76 62 22 61 0.891 
History of PTCA/CABG 32 26 4 11 0.060 
Poor control HBP 41 33 23 64 0.001 
Surgery for AAA 63 51 22 61 0.317 
Creatinine > 1.5 mg/dl 32 26 18 50 0.003 
HBP improved by operation 41 33 4 11 0.010 
~Operative deaths censored 
PTCA, Percutaneous transhmainal coronary angioplasty; HBP, hypertension. 
angioplasty are available to the surgeon treating 
combined aortic and renal artery lesions. Our data 
indicate that RAS of 50% severity or greater was 
bilateral in nearly 40% of patients, and in recently 
treated patients bilateral renovascular repair (exclud- 
ing nephrectomy) is performed in 25% of patients 
undergoing the combined procedure. This represents 
a change in practice compared with patients treated 
before 1990 when bilateral repair was performed in 
only 3% of patients. This reflected apreference for a 
staged repair in prior practice often involving an 
initial hepatorenal bypass followed at a later interval 
by a combined aortic and left renal artery graft.17 This 
approach ad appeal in patients with advanced renal 
insufficiency because the entire functioning renal 
mass is not rendered ischemic at a single operative 
setting. However, experience has proven that most 
patients who require bilateral repair can be treated 
with a bilateral simultaneous reconstruction. Al- 
though Tarazi et al)8 reported increased mortality 
rates for patients undergoing bilateral as opposed to 
unilateral repair, they emphasized that patients who 
required bilateral repair had more advanced heart and 
kidney disease. Coincident with a higher incidence of 
bilateral repair has been the increasing use of 
transaortic endarterectomy as a reconstructive t ch- 
nique, currently applied in two thirds of our patients 
who underwent bilateral repair. Although endarter- 
ectomy has been championed by Stoney et al.19 for 
some time, most clinical series reported over the past 
decade have emphasized bypass grafting as the 
principal reconstructive technique. Indeed, if the San 
Francisco series are excluded, a review of 13 modern 
reports indicates that renal artery bypass has been 
applied in 80% of patients treated with the combined 
operation. ~ The long-term durability of this bypass 
graft has been amply demonstrated and remains our 
procedure of choice for patients requiring unilateral 
renal artery reconstruction. 11 However, because a 
majority of renovascular disease is so-called "spill- 
over" aortic atherosclerosis and thereby limited to the 
proximal renal artery, transaortic endarterectomy is 
~References 6-8, 11, 18, 20-27. 
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an effective technique with durability equivalent to a 
side-arm aortorenal bypass originating from an aortic 
graft in our experience. Others have emphasized the 
increased application of endarterectomy as a recon- 
structive technique incurrent practice. 9,28 Transaortic 
endarterectomy does require complete dissection of 
the visceral aortic segment and a series of technical 
maneuvers that have been reviewed lsewhere. 16,29 
Surgical results 
Our recently reported n cumulative xperience 
with renovascular repair emphasized what must be 
considered "conventional wisdom" with respect o 
operative risk of the combined operation; that is, the 
operative mortality rate appeared unsatisfactory 
when compared with either procedure performed 
independently. In the literature reported before 
1984, Operative mortality rates in excess of 10% for 
the combined operation were common. 2azs We 
noted an 8.5% mortality rate for the combined 
operation during the interval 1976 to 1991.11 
Whereas uch figures would be considered unaccept- 
able in contemporary practice, our experience ap- 
peared to confirm a bias against extending the 
operation unless independent criteria existed for 
treatment of both the aortic and renal artery lesions. 
A literature survey of experience with the combined 
operation over the past decade and representing 
experience in 1000 patients indicates amean opera- 
rive mortality rate of 6.5% (range 2% to 12%).t The 
current operative mortality rate of 2% in group II 
patients reported herein is consistent with that of 
other modern reports (range 1% to 4.9%) and in the 
range expected for aortic surgery alone. 69 With 
respect to comparisons of operative mortality rates 
between patient groups undergoing aortic surgery 
alone versus combined operation, our data suggest 
that such comparisons are irrelevant because of the 
widely discrepant risk factor profiles of the two 
patient groups. Prominent in this profile is the 
striking difference in both clinically suspected and 
radiographically documented CAD. Valentine t al. 3 
have recently documented the associated coronary 
risk of even unsuspected renovascular disease, dem- 
onstrating a correlation between the severity of the 
renovascular and coronary artery disease. Other 
contemporary reports have emphasized the frequent 
association of coronary artery and renovascular 
disease. In a report of the combined operation from 
the Cleveland Clinic, 70% of patients underwent 
coronary angiography, and 28% had preoperative 
~References 6-8, 11, 18, 20-27, 29. 
coronary artery bypass grafting (CABG). 18 Hallett et 
al. 13 noted myocardial infarction (not kidney failure) 
as the principal cause of early and late death in a series 
of patients who underwent surgery for renovascular 
disease in the presence of a creatinine of 2.0 mg/dl or 
greater. Our group II patients who underwent com- 
bined operation during the interval 1990 to 1994 
were evaluated for concomitant CAD frequently, 
representing a significant change in overall treatment 
compared with earlier practice (Table II). By way of 
comparison with a cohort of patients undergoing 
isolated aortic surgery recently reported from our 
institution (Table VI), 3° it is evident hat patients 
who undergo the combined operation in current 
practice have an increased coronary risk profile and 
frequently undergo noninvasive and invasive evalua- 
tion of associated CAD; 40% of such patients cur- 
rently come to surgery with antecedent mechanical 
intervention for their CAD. Although it cannot be 
proven that such management of associated CAD is 
even partly responsible for the currently favorable 
surgical results, it has, in our view, been an important 
factor in bringing operative risks of the combined 
operation into he range anticipated for isolated aor- 
tic surgery. 
Surgical decision making 
A common dilemma facing the vascular surgeon 
is when to recommend repair of so-called "inciden- 
tally" discovered renovascular lesions during the 
course of evaluation for aortic disease. It is clear that 
such discovery is common. An early report from our 
institution indicated that important renovascular 
lesions were found in some 25% of patients under- 
going angiography before AAA repair. 2Corrobora- 
tive data from Valentine et al. 3 and Olin et al.1 
indicate that 50% or greater stenosis of the renal 
arteries is detected in approximately one third of 
patients undergoing angiography for AAA/MOD, 
and the report of Valentine t al.a documented an 
association with hypertension (albeit controlled) and 
mild renal insufficiency. Their data mirror a common 
clinical scenario, namely, such "incidentally" discov- 
ered renovascular lesions are often not functionally 
silent when viewed in retrospect and in the context of 
a patient requiring multiple medications to control 
hypertension r coronary artery ischemia. Interven- 
tion for an incidentally discovered renal artery lesion 
presumes ome benefit when compared with the 
natural history of the disease untreated or with 
medical therapy of hypertension. Two recently avail- 
able studies have produced similar information rela- 
tive to the natural history of renal artery stenoses. The 
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Table VI. Evaluation and management of CAD 
Combined operation 1990-1994 
(n = 60) 
Isolated aortic surgery 1989-1990 
(n = 202)* 
Variable No. % No. % p Value 
Patients with _> 2 CAD markerst 39 
% with preoperative D-Thai 35 
% with preoperative cor anglo 17 
preop IWCA/CABG 24 
65 56 28 <0.0001 
58 58 29 <0.0001 
28 16 8 < 0.0001 
40 42 20 <0.003 
D-Thal, Dipyridamole-thallium scintigraphy; Cor angio, coronary angiography; PTCA, percutaneous coronary angioplasty. 
~Adapted from ref. 30. 
tCAD markers include diabetes, age of 70 years or older, and history of angina, myocardial infarction or congestive heart failure. 
study of Tollefson et al. 4 is unique in that the renal 
artery lesions were detected specifically during the 
angiographic evaluation of aortic disease and sequen- 
tial angiograms were available at  mean of 4.5 years 
apart. These investigators noted progression of dis- 
ease in 50% of renal artery lesions and progression to 
total occlusion in 15% of diseased arteries. All vessels 
that developed progression to occlusion harbored 
high-grade ( _> 80%) stenoses at the time of initial 
evaluation. 4 Zierler et al) noted progression ofreno- 
vascular disease in 40% of diseased arteries after 2 
years of follow-up. Progression to occlusion occurred 
in 11% of arteries initially noted to harbor 60% or 
greater lesions. The clinical consequences of progres- 
sion to total occlusion were variable in these reports 
but emphasize findings in the earlier literature, 
namely that following clinical parameters is an unre- 
liable tool for monitoring the progression f renovas- 
cular disease. 3~-33 Clinical deterioration often implies 
lesion progression to total arterial occlusion, at which 
point some irreversible loss of renal parenchyma has 
likely already occurred. Prophylactic repair of asymp- 
tomatic renal artery stenoses has been loosely defined 
as repair of lesions in the absence of hypertension or
renal insufficiency and has been the indication for 
renovascular repair in 30% of modern series where an 
aggressive posture to the "clinically silent" renovascu- 
lar lesion has been advocated. 7,9 By these criteria, 5% 
of our patients underwent "prophylactic" repair and 
the corresponding figure from a survey of the recent 
literature is a mean of 13.5% (range 0% to 31%).~: 
This in no way implies a renovascular o igin for the 
hypertension i many of our patients. In our unit, 
patients with hypertension or renal insufficiency ad- 
mitted for aortic surgery and in whom significant 
renovascular lesions are discovered undergo com- 
bined repair. In circumstances where the renal artery 
lesion is clinically silent, combined operation may be 
SReferences 6, 8, 11, 18, 20-27. 
selected after consideration of the patient's overall 
risk profile. After such consideration, current practice 
in our unit is consistent with that recently advocated 
by others in favor of prophylactic renal artery repair 
for high-grade lesions because the current safety and 
results of surgery compare favorably with the avail- 
able natural history data relative to high-grade renal 
artery stenoses.4,5,7,9 Ultimately, prospective random- 
ized studies will be needed to clarify the role of renal 
artery reconstruction i  this clinical setting. 
Functional and late outcome 
Comparisons of functional response to operation 
reported herein and that noted in other reports is 
problematic because of varying methods for defining 
or absence of follow-up information. Furthermore, 
although identifiable criteria for blood pressure 
response are standardized to a degree, ~5 no con- 
sensus exists concerning what constitutes a favorable 
renal function response. In our group II patients, 
a sustained (at 2-year follow-up) favorable response 
in hypertension control was seen in 70%, compa- 
rable with other recent series. 2~,22 Renal function 
response in our patients appeared favorable, al- 
though the retrospective nature of this review and 
the high percentage of patients treated primarily for 
aortic disease permit no more than inference in this 
regard. The single group II paticnt with an initial 
creatinine of 4.0 who began undergoing dialysis was 
balanced by another patient in whom dialysis was 
discontinued after operation. Prediction of renal 
function response to renovascular operation remains 
an inexact science, worthy of further prospective 
study. Late survival rates in our patients were both 
favorable (75% actuarial 5-year survival rate) and 
in the upper range in those reports wherein late 
follow-up is included. 68,~3,~8,2°23 We note the nega- 
tive impact of the sequelae of renovascular disease 
(Table V) and the apparent protective role of 
mechanical treatment of associated CAD. 
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This report emphasizes that in contemporary 
practice, the surgical mortality rate associated with 
combined aortic and renal artery reconstruction is in 
the range anticipated for aortic surgery alone, despite 
widely different risk factor profiles of the two patient 
groups. Our longitudinal perspective suggests that 
more aggressive evaluation and treatment of the 
frequently associated CAD has been an important 
contributing factor in this evolution. Current surgical 
results, coupled with recently available natural history 
data relative to renovascular disease, suggest hat an 
aggressive approach to even "asymptomatic" renal 
artery lesions discovered uring evaluation of aortic 
disease may be appropriate in those environments 
with demonstrated surgical expertise. 
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DISCUSSION 
Dr. John Mannick (Boston, Mass.). Would you 
discuss the change in attitude that your group has 
undergone since your report in the JOURNAL OF VASCULAR 
SURGERY? 11 That study contains areport of 120 or so of the 
present 170 patients, and in the discussion the authors had 
a somewhat gloomy attitude toward the combined aortic 
and renal artery reconstruction technique, believing that 
the high mortality and morbidity rates made one want to 
be very careful about recommending this procedure. Now 
I gather that by reviewing the last 31/2 years of experience 
they have changed their minds, and I just wanted to have 
Dr. Cambria reassure us that he would now recommend 
doing combined renal artery reconstruction and aortic 
reconstruction i those patients with aortic disease who 
have asymptomatic high-grade renal artery stenoses even 
though they have no manifestations of kidney failure or 
uncontrollable hypertension. 
The second thing that I wanted to ask him about has 
to do with the division of the patients in his series into two 
groups. Obviously when you review a series of patients 
retrospectively, it is tempting to put a division in the series 
whenever the r suks start to look good, and we probably 
ought to have some other reason for dividing groups than 
that. The stated reason is that CAD began to get sufficient 
attention in 1990. I suspect that at Mass General, attention 
to CAD in patients undergoing aortic reconstruction was 
definitely common before 1990. What other real change in 
patient reatment occurred in 1990 to cause this division 
into modern and not-so-modern groups? We might learn 
something more about the progressive volution in the 
safety of this procedure if he could tell us what the results 
were in each 5-year period of the 15 or so years he is 
reporting on rather than simply dividing the series into 
before 1990 and 1990 and beyond. 
Dr. Richard P. Cambria. With respect o the appli- 
cation of the combined operation, the perspective of the 
surgeon is guided by the nature of the aortic disease. In the 
report Dr. Mannick referred to, we did indeed recommend 
against application of the combined procedure for the sole 
purpose of providing a source of inflow for renal artery 
reconstruction, believing that there are a number of other 
alternative methods-hepatorenal, splenorenal and so 
for th-  for renal artery reconstruction. We still believe that 
prophylactic or incidental correction of aortic atheroscle- 
rosis in patients who require renal revascularization is not 
called for unless the aortic disease on its own merits requires 
resection. There are indeed a few patients in whom there is 
,no alternative other than replacing the aorta exits merely to 
facilitate their renal artery reconstruction. These are a 
minority of patients. We believe that origination of an 
aortorenal bypass from a heavily diseased infrarenal aorta is 
not a wise thing to do because there are better akernative 
options. In this series, patients who undergo the combined 
operation have a clear-cut indication to resect heir aortic 
disease. 
With respect o the temporal division of the cohort, 
admittedly that is entirely arbitrary. It was engendered, 
if you will, by the somewhat sobering realization that we 
had an 8.5% mortality rate for the combined operation 
over the 15-year interval, 1976 to 1990. In fact, in that 
original report when I sought o determine whether we 
had had some improvement over that time interval, the 
mortality rate was nearly equal in the 1976-to-1981, as 
opposed to the 1981-to-1989 time interval, but we 
believed it was clearly not representative of current 
practice, and that was the sort of thing that spurred the 
temporal division of the cohort. It is certainly true that 
we have been writing about aggressive valuation of 
associated CAD since 1985, and you will shortly hear a 
report about that experience. This report emphasizes that 
an aggressive posture toward CAD has been an important 
factor in patients undergoing the combined operation. 
Antecedent treatment of CAD occurred in only 10% of 
patients treated before 1990, whereas 40% of currently 
treated patients had antecedent percutaneous transluminal 
coronary angioplasty or CABG. 
Dr. Mannick. What do you recommend for the patient 
who has a clear-cut indication for aortic surgery and bilat- 
eral high-grade renal artery stenosis that is asymptomatic? 
Dr. Cambria. In current practice we believe that the 
available natural history data suggest hat these lesions 
should be repaired. 
